Bicycle Therapeutics PLC
NASDAQ:BCYC

Watchlist Manager
Bicycle Therapeutics PLC Logo
Bicycle Therapeutics PLC
NASDAQ:BCYC
Watchlist
Price: 14.485 USD -1.33%
Market Cap: 1B USD
Have any thoughts about
Bicycle Therapeutics PLC?
Write Note

Bicycle Therapeutics PLC
Effect of Foreign Exchange Rates

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bicycle Therapeutics PLC
Effect of Foreign Exchange Rates Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Effect of Foreign Exchange Rates CAGR 3Y CAGR 5Y CAGR 10Y
Bicycle Therapeutics PLC
NASDAQ:BCYC
Effect of Foreign Exchange Rates
$2.4m
CAGR 3-Years
99%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Effect of Foreign Exchange Rates
$615k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Exscientia PLC
NASDAQ:EXAI
Effect of Foreign Exchange Rates
-ÂŁ2.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Effect of Foreign Exchange Rates
$15m
CAGR 3-Years
181%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Effect of Foreign Exchange Rates
ÂŁ8.3m
CAGR 3-Years
N/A
CAGR 5-Years
283%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Effect of Foreign Exchange Rates
-ÂŁ1.5m
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
2%
No Stocks Found

Bicycle Therapeutics PLC
Glance View

Market Cap
999.7m USD
Industry
Biotechnology

Bicycle Therapeutics PLC, a pioneering force in biotechnology, was founded on a unique vision to transform medicine using a novel class of therapeutics known as Bicycles®. These are synthetic short peptides that combine the pharmacological capabilities of biologics with the manufacturing and distribution advantages of small molecules. The company's scientific ingenuity, originating from Cambridge, UK, has enabled it to engineer and develop a pipeline of drugs targeting areas with significant unmet medical needs, primarily in oncology and other severe diseases. Bicycle leverages its distinctive platform technology to design therapeutic candidates that offer high specificity and affinity, focusing on targets that have traditionally been challenging for conventional biologics and small molecules. Monetizing this innovative biotechnology hinges on Bicycle's strategic partnerships and collaborations with major pharmaceutical firms. These alliances allow the company to amplify its reach while sharing the risks and costs associated with drug development. By licensing their Bicycle® technology and therapeutic candidates to larger entities, Bicycle benefits from milestone payments and royalty streams, creating a sustainable revenue model. The company's revenue stream is thus a blend of upfront payments for access to their platform technology and the potential downstream success of these partners in developing and commercializing new therapeutic agents. Their unique approach and strong collaboration network position Bicycle Therapeutics at the forefront of next-generation drug discovery, striving to reshape treatment paradigms across multiple therapeutic areas.

BCYC Intrinsic Value
9.024 USD
Overvaluation 38%
Intrinsic Value
Price

See Also

What is Bicycle Therapeutics PLC's Effect of Foreign Exchange Rates?
Effect of Foreign Exchange Rates
2.4m USD

Based on the financial report for Sep 30, 2024, Bicycle Therapeutics PLC's Effect of Foreign Exchange Rates amounts to 2.4m USD.

What is Bicycle Therapeutics PLC's Effect of Foreign Exchange Rates growth rate?
Effect of Foreign Exchange Rates CAGR 3Y
99%

Over the last year, the Effect of Foreign Exchange Rates growth was -34%. The average annual Effect of Foreign Exchange Rates growth rates for Bicycle Therapeutics PLC have been 99% over the past three years .

Back to Top